Trial document





This trial has been registered retrospectively.
drksid header

  DRKS00017548

Trial Description

start of 1:1-Block title

Title

Evaluation of the outpatient healthcare contract of the AOK for patients with orthopaedic diseases according to §73c SGB V in Baden-Wurttemberg

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

EVAL FAV Ortho

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

German health policy legislation (§73c SGB V) allow contracts between Statutory Health Insurances (SHI) and outpatient physicians (general practitioners and specialists) to enable special and innovative programs of healthcare. To optimize healthcare for patients with orthopaedic diseases, an applicable contract was concluded between the largest SHI in Baden-Wurttemberg (AOK Baden-Wurttemberg) and SHI-accredited orthopaedic surgeons. The contract entails different quality arrangements and incentives.
The aim of this scientific evaluation is to study the effects of this contract on healthcare quality and costs. It will compare patients participating in the program with patients treated in the regular healthcare setting.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

German health policy legislation (§73c SGB V) allow contracts between Social Health Insurances (SHI) and outpatient physicians (general practitioners and specialists) to enable special and innovative programs of healthcare. To optimize healthcare for patients with orthopaedic diseases, such a contract was concluded between the largest SHI in Baden-Wurttemberg (AOK Baden-Wurttemberg) and SHI-Accredited orthopaedic surgeons. The contract entails different quality arrangements and incentives.
For evaluation of the contract, a cohort of patients participating in the program (intervention group) will be compared to a cohort of patients in regular healthcare (control group). Healthcare within the program is conceptualized as a complex intervention* including aspects of managed and integrated care. Quality measures include specific requirements for participating orthopaedic surgeons, targeted improvement of evidence-based pharmacotherapy and treatment according to current practice guidelines. Furthermore interaction of primary care and specialist care is being optimized.
The study design is a retrospective analysis (descriptive and multivariate statistics) of insurance claims data of the AOK Baden-Wuerttemberg. Indicators for medical treatment quality and outcomes as well as health economic analysis will be conducted.
* The study is a retrospective evaluation of the program, no intervention within the study itself will be conducted.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00017548
  •   2019/08/02
  •   [---]*
  •   yes
  •   Approved
  •   338/18, Ethikkommission des Fachbereichs Humanmedizin der Johann-Wolfgang-Goethe-Universität Frankfurt am Main
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   nonspecific back pain, lower back pain, specific back pain, osteoporosis
  •   M16 -  Coxarthrosis [arthrosis of hip]
  •   M17 -  Gonarthrosis [arthrosis of knee]
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Patients enrolled in the Orthopaedic HealthCare program:
    Routine data from AOK insurants with orthopaedic diseases in 2014 to 2017 enrolled in the Orthopaedic Healthcare Program is analyzed in regard to HealthCare Quality and Health economic aspects.
  •   Patients enrolled in regular healthcare
    Routine data from AOK insurants with orthopaedic diseases in 2014 to 2017 in regular healthcare is analyzed in regard to healthcare quality and health economic aspects.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Epidemiological study
  •   Non-randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Other
  •   Health care system
  •   Other
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Multiple indicators for medical care quality (claim of insurance services, pharmacotherapy, clinical outcomes), aspects of health economics. Outcome analysis for 2016 and 2017.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

[---]*

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • other 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2018/12/10
  •   [---]*
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

The cohort enrolled in the programme is condsidered the "interventional group" and patients treated by regular GPs and Orthopaedic surgeons as control group. All patients were treated for orthopaedic diseases. The evaluation is based on retrospective routine data analysis of data from AOK insurants from 2014 to 2017.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Interruption of enrollment in AOK or Orthopaedic contract insurance (except cases of death 2015-2017),
under-aged patients on Jan 1st 2015,
patients enrolled in another health care program,
zip code of patient or doctor not within Baden-Württemberg

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Institut für Allgemeinmedizin der Goethe-Universität Frankfurt
    • Theodor-Stern-Kai 7
    • 60590  Frankfurt
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Institut für Allgemeinmedizin Goethe-Universität Frankfurt am Main
    • Ms.  Dr. med.  Angelina  Müller 
    • Theodor-Stern-Kai 7
    • 60590  Frankfurt
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Institut für Allgemeinmedizin der Goethe-Universität Frankfurt
    • Ms.  Dr. med.  Angelina  Müller 
    • Theodor-Stern-Kai 7
    • 60590  Frankfurt
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Innovationsausschuss beim Gemeinsamen Bundesausschuss
    • Wegelystraße 8
    • 10623  Berlin
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2019/08/01
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.